Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to
assess the efficacy and safety of Magnesium-vitamin B6in combination with treatment as usual
for treating symptoms of depression, stress, and anxiety in patients with first episode
bipolar I disorder.